
In this acute study, we evaluated the real-time glucose response to Feel Great. Subjects followed a self-selected, habitual diet, and incorporated the Feel Great program as directed during the study period. Within a short duration, Feel Great significantly reduced Baseline glycemic variability by 12%. Reducing glycemic variability is a therapeutic target in diabetes, and these short-term improvements with Feel Great may contribute to better health outcomes in the areas of oxidative stress, inflammation, and cardiovascular health in the long-term.